Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Leukemia, Myeloid, Acute 2Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Melanoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Congenital Abnormalities 1Breast Neoplasms 1Blast Crisis 1

Interventions

Cyclophosphamide 72fludarabine phosphate 64Peripheral Blood Stem Cell Transplantation 64Busulfan 50Cyclosporine 48Mycophenolic Acid 45Tacrolimus 41Antilymphocyte Serum 41Radiotherapy 37Whole-Body Irradiation 33Methotrexate 33Filgrastim 33Imatinib Mesylate 27Methylprednisolone 25Cord Blood Stem Cell Transplantation 24Melphalan 22Dasatinib 16sargramostim 15Etoposide 15nilotinib 14Cytarabine 14Interferon-alpha 13Therapeutics 11Flow Cytometry 11Cyclosporins 11Thiotepa 9Sirolimus 9Alemtuzumab 9Polymerase Chain Reaction 8Psychiatric Rehabilitation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Myeloid, Chronic-Phase × alvocidib × Clear all
NCT00064285 2010-05-03

Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

Virginia Commonwealth University

Phase 1 Completed
22 enrolled
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡